What question did this study set out to answer?

To assess the relationship between maternal serum YKL-40 levels and the severity of placenta accreta spectrum.

April 5, 2026Journal of the Faculty of Medicine Baghdad0 citationsOpen Access

Role of YKL-40 in Diagnosing Placenta Accreta Spectrum in Iraqi Patients

The Role of YKL-40 in the Diagnosis of Placenta Accreta Spectrum in a Group of Iraqi Patients

View Full Paper

Ask AI

Bookmark

Authors

Case-control study evaluates YKL-40 as a biomarker for placenta accreta spectrum severity in pregnant women, suggesting its diagnostic potential.

To assess the relationship between maternal serum YKL-40 levels and the severity of placenta accreta spectrum.
Conducted a case-control study at Baghdad Teaching Hospital.
Included 97 pregnant women in their third trimester: 37 with placenta accreta spectrum and 60 controls with normal placenta.
Measured serum YKL-40 levels in both groups.
Higher mean YKL-40 levels found in patients with placenta accreta spectrum compared to controls.
YKL-40 cut-off point of 112.68 pg/ml associated with the diagnosis of placenta accreta spectrum.
Significant correlation between YKL-40 levels and depth of placental invasion.

Meran et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

April 5, 2026Journal of the Faculty of Medicine Baghdad0 citationsOpen Access

The Role of YKL-40 in the Diagnosis of Placenta Accreta Spectrum in a Group of Iraqi Patients

View Full Paper

Ask AI

Bookmark

Authors

Case-control study evaluates YKL-40 as a biomarker for placenta accreta spectrum severity in pregnant women, suggesting its diagnostic potential.

To assess the relationship between maternal serum YKL-40 levels and the severity of placenta accreta spectrum.
Conducted a case-control study at Baghdad Teaching Hospital.
Included 97 pregnant women in their third trimester: 37 with placenta accreta spectrum and 60 controls with normal placenta.
Measured serum YKL-40 levels in both groups.
Higher mean YKL-40 levels found in patients with placenta accreta spectrum compared to controls.
YKL-40 cut-off point of 112.68 pg/ml associated with the diagnosis of placenta accreta spectrum.
Significant correlation between YKL-40 levels and depth of placental invasion.

Meran et al. (2026) studied this question.

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark